GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma.
Maria ScatoliniA PatelE GrossoMaurizia Mello-GrandPaola OstanoR CoppoM VitielloT VenesioA ZaccagnaA PisacaneI SarottoD TavernaL PolisenoDaniele BergamaschiGiovanna ChiorinoPublished in: The British journal of dermatology (2021)
We identified a significant association between metastases/BRAF mutation and low GJB5 expression in melanoma. Our results identify a novel mechanism of gap-junctional protein regulation, suggesting a prognostic role for GJB5 in cutaneous melanoma.